29 February 2024
Karelian
Diamond Resources plc
(“Karelian”
or “the Company”)
Half-yearly
results for the six months ended 30 November
2023
Karelian
Diamond Resources plc (AIM: KDR), the diamond exploration company
focused on Finland, announces its
unaudited results for the six months ended 30 November 2023.
Details of
these can be found below and a full copy of the interim results
statement can be viewed on the Company’s website
(www.kareliandiamondresources.com).
The period was one of steady progress, particularly in working
towards opening the first diamond mine.
Highlights
of the half-year period included:
-
The
proceedings to establish the mining concession for the applied for
area at the Lahtojoki diamond deposit are now at an advanced
stage.
-
Mining
concession at Lahtojoki is expected to be approved, now the last of
the compensation appeals are being finalised. This follows prior
approvals by TUKES, the Finnish mining
authority.
-
Exploration
programme in the Kuhmo region of Finland continues to be highly encouraging
with results from basal till sampling suggesting that two of the
sample locations may be close to the source of the green diamond
the Company discovered.
-
Work continues in Northern Ireland
on the nickel, copper and platinum mineralisation
anomalies.
-
Post Period: 3 year extension granted for Exploration Permit
covering the
Riihivaara
Kimberlite discovery and adjacent areas.
Professor Richard Conroy,
Chairman of Karelian, said:
“We
are very pleased with
the
Company’s progress regarding the planned development of the mine at
the Lahtojoki diamond deposit, the work to find the source of the
green diamond and, post period, the extension of the exploration
permits which will allow the Company to continue its work on the
emerging kimberlite field at Kuhmo.
Overall,
it has been a very satisfactory period for the exploration
team.”
Further
Information:
Karelian
Diamond Resources plc
Professor
Richard Conroy, Chairman
|
+353-1-479-6180
|
Allenby
Capital Limited (Nomad)
Nick
Athanas / Nick Harriss
|
+44-20-3328-5656
|
Peterhouse
Capital Limited (Broker)
Lucy
Williams / Duncan Vasey
|
+44-20-7469-0930
|
Lothbury
Financial Services
Michael
Padley
|
+44-20-3290-0707
|
Hall
Communications
Don
Hall
|
+353-1-660-9377
|
http://www.kareliandiamondresources.com
|
|
Chairman’s
Statement
Dear
Shareholder,
I have
great pleasure in presenting the Company’s Half-Yearly Report and
condensed Financial Statements for the half year ended 30 November 2023.
The period
was one of continued progress in relation to the development of the
Lahtojoki diamond deposit in the Kuopio-Kaavi region of
Finland. The proceedings to
establish the mining concession are now at an advanced
stage.
A mining
concession application has already been approved by TUKES (the
Finnish mining authority). Following the order of TUKES, the
National Land Survey has carried out the process in relation to
ground rental compensation for the local landowners and is now
finalising the appeals by two landowners regarding the amount of
compensation and the mine boundary.
Land
possession for the duration of the mine is a major step forward in
the Company’s proposed development of the Lahtojoki deposit. The
diamond mining project covers 71 hectares (c.176 acres) with the
actual kimberlite pipe having a surface area of 16 hectares (c.40
acres).
The
deposit, as well as containing high quality colourless gem
diamonds, contains pink diamonds which are highly sought after and
can command prices up to 20 times that of normal colourless gem
diamonds.
I believe
the development of a diamond mine at Lahtojoki will not only bring
significant benefits to the Company, but also to the entire
surrounding Kuopio-Kaavi area and, when in production, is expected
to be the first diamond mine in Europe outside Russia.
The
Company’s exploration programme in the Kuhmo region of Finland continues to be highly encouraging
up-ice of the Company’s discovery of a green diamond. Results from
the Company’s basal till sampling suggest that two of the sample
locations may be close to the source of the green
diamond.
The
Company’s nickel, copper and platinum mineralisation exploration
project in Northern Ireland also
continues to be very encouraging.
Exercise of Warrants
During the
period the Company received warrant exercise notices to subscribe
for a total of 600,000 new ordinary shares of nominal value
€0.00025 each at an exercise price of 2
pence per ordinary share, as announced by the Company on
11 October 2023.
Finance
During the
period there was a fundraising of £250,000 (including £100,000 from
Board members) at 2.5 pence per
ordinary share.
Following
admission of these new ordinary shares, in relation to the
fundraising and exercised warrants, the Company had a total of
105,092,749 ordinary shares in issue.
The loss
after taxation for the half year ended 30
November 2023 was €136,351 (30
November 2022: loss of €168,786) and the net assets as at
30 November 2023 were €9,832,149
(30 November 2022:
€9,312,017).
Directors and Staff
I would
like to thank my fellow directors, staff and consultants for their
support and dedication, which has enabled the continued success of
the Company.
Future Outlook
I look
forward to the Company continuing to progress the planned
development of the Lahtojoki diamond deposit and also to further
success with its diamond exploration in Finland and the identification of a kimberlite
pipe, as well as to further positive results from the exploration
programme for nickel, copper and platinum group metals in
Northern Ireland.
Yours
faithfully,
Professor
Richard Conroy
Chairman
28 February 2024
Condensed income statement
|
|
|
|
|
|
|
|
Note
|
Six-month
period ended 30 November
2023
(Unaudited) €
|
|
Six-month
period ended 30 November 2022
(Unaudited)
€
|
|
Year
ended 31 May 2023
(Audited)
€
|
Continuing
operations
|
|
|
|
|
|
|
Operating
expenses
|
|
(255,240)
|
|
(165,140)
|
|
(297,386)
|
Movement
in fair value of warrants
|
6
|
122,128
|
|
-
|
|
9,565
|
|
|
|
|
|
|
|
Operating
loss
|
|
(133,112)
|
|
(165,140)
|
|
(287,821)
|
|
|
|
|
|
|
|
Interest
expense
|
|
(3,239)
|
|
(3,646)
|
|
(3,646)
|
|
|
|
|
|
|
|
Loss
before taxation
|
|
(136,351)
|
|
(168,786)
|
|
(291,467)
|
|
|
|
|
|
|
|
Income
tax expense
|
|
-
|
|
-
|
|
-
|
Loss
for the financial period/year
|
|
(136,351)
|
|
(168,786)
|
|
(291,467)
|
Loss per share
|
|
|
|
|
|
|
Basic and
diluted earnings/(loss) per share
|
2
|
(0.0014)
|
|
(0.0025)
|
|
(0.0038)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed statement of comprehensive
income
|
|
Six-month
period ended 30 November 2023
(Unaudited)
€
|
|
Six-month
period ended 30 November 2022
(Unaudited)
€
|
|
Year
ended 31 May 2023
(Audited)
€
|
|
|
|
|
|
|
|
Loss
for the financial period/year
|
|
(136,351)
|
|
(168,786)
|
|
(291,467)
|
|
|
|
|
|
|
|
Income/(expense)
recognised in other comprehensive income
|
|
-
|
|
-
|
|
-
|
|
|
|
|
|
|
|
Total
comprehensive income/(expense) for the financial
period/year
|
|
(136,351)
|
|
(168,786)
|
|
(291,467)
|
Condensed statement of financial
position
|
Note
|
30
November 2023 (Unaudited)
|
|
30
November 2022 (Unaudited)
|
|
Year
ended 31 May 2023 (Audited)
|
|
|
€
|
|
€
|
|
€
|
Assets
|
|
|
|
|
|
|
Non-current
assets
|
|
|
|
|
|
|
Intangible
assets
|
3
|
11,439,845
|
|
10,989,210
|
|
11,265,894
|
Financial
assets
|
|
-
|
|
-
|
|
-
|
Total
non-current assets
|
|
11,439,845
|
|
10,989,210
|
|
11,265,894
|
|
|
|
|
|
|
|
Current
assets
|
|
|
|
|
|
|
Cash and
cash equivalents
|
|
215,025
|
|
90,177
|
|
116,038
|
Other
receivables
|
|
57,834
|
|
36,034
|
|
79,003
|
Total
current assets
|
|
272,859
|
|
126,211
|
|
195,041
|
|
|
|
|
|
|
|
Total
assets
|
|
11,712,704
|
|
11,115,421
|
|
11,460,935
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
Capital
and reserves
|
|
|
|
|
|
|
Called up
share capital presented as equity
|
|
3,203,532
|
|
3,191,807
|
|
3,200,882
|
Share
premium
|
|
10,726,620
|
|
9,959,181
|
|
10,546,844
|
Share
based payments reserve
|
|
450,658
|
|
450,658
|
|
450,658
|
Retained
losses
|
|
(4,548,661)
|
|
(4,289,629)
|
|
(4,412,310)
|
Total
equity
|
|
9,832,149
|
|
9,312,017
|
|
9,786,074
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
Non-current
liabilities
|
|
|
|
|
|
|
Convertible
loan
|
|
122,483
|
|
-
|
|
119,246
|
Warrant
liabilities
|
5
|
95,606
|
|
-
|
|
109,224
|
Derivative
liability
|
|
10,304
|
|
146
|
|
10,304
|
Total
non-current liabilities
|
|
228,393
|
|
146
|
|
238,774
|
|
|
|
|
|
|
|
Current
liabilities
|
|
|
|
|
|
|
Trade and
other payables: amounts falling due within one year
|
|
1,652,162
|
|
1,632,822
|
|
1,436,087
|
Convertible
Loan
|
6
|
-
|
|
170,436
|
|
-
|
Total
current liabilities
|
|
1,652,162
|
|
1,803,258
|
|
1,436,087
|
|
|
|
|
|
|
|
Total
liabilities
|
|
1,880,555
|
|
1,803,404
|
|
1,664,859
|
|
|
|
|
|
|
|
Total
equity and liabilities
|
|
11,712,704
|
|
11,115,421
|
|
11,460,935
|
Condensed statement of cash
flows
|
Six-month
period ended 30 November 2023 (Unaudited) €
|
|
Six-month
period ended 30 November 2022 (Unaudited) €
|
|
Year
ended 31 May 2023 (Audited)
€
|
Cash
flows from operating activities
|
|
|
|
|
|
(Loss) for
the financial period/year
|
(136,351)
|
|
(168,786)
|
|
(291,467)
|
Adjustments
for:
|
|
|
|
|
|
Interest
expenses
|
3,239
|
|
3,646
|
|
3,646
|
Movement
in fair value of warrants
|
(122,128)
|
|
-
|
|
109,224
|
(Decrease)/increase
in trade and other payables
|
200,825
|
|
191,584
|
|
1,361
|
Decrease/(increase)
in other receivables
|
21,168
|
|
24,144
|
|
(18,825)
|
Advances
from/(repayments to) Conroy Gold and Natural Resources
P.L.C
|
15,250
|
|
-
|
|
119,246
|
Net
cash provided by/(used in) operating activities
|
(17,997)
|
|
50,588
|
|
(76,815)
|
|
|
|
|
|
|
Cash
flows from investing activities
|
|
|
|
|
|
Investment
in exploration and evaluation
|
(173,951)
|
|
(78,279)
|
|
(354,963)
|
Net
cash used in investing activities
|
(173.951)
|
|
(78,279)
|
|
(354,963)
|
|
|
|
|
|
|
Cash
flows from financing activities
|
|
|
|
|
|
Issue of
share capital
|
299,555
|
|
-
|
|
453,109
|
Share
issue costs
|
(8,620)
|
|
-
|
|
(23,161)
|
Net
cash provided by financing activities
|
290,935
|
|
-
|
|
429,948
|
|
|
|
|
|
|
Increase
in cash and cash equivalents
|
98,987
|
|
(27,291)
|
|
(J,830)
|
Cash
and cash equivalents at beginning of financial
period/year
|
116,038
|
|
117,868
|
|
117,868
|
Cash
and cash equivalents at end of financial
period/year
|
215,025
|
|
90,177
|
|
116,038
|
Condensed statement of changes in
equity
|
Share
capital (including deferred share capital)
|
Share
premium
|
Share-based
payment reserve
|
Retained
losses
|
Total
equity
|
|
€
|
€
|
€
|
€
|
€
|
Balance
at 1 June 2023
|
3,200,882
|
10,546,844
|
450,658
|
(4,412,310)
|
9,786,074
|
Issue of
share capital
|
2,650
|
296,905
|
-
|
-
|
299,555
|
Share
issue costs *
|
-
|
(8,620)
|
-
|
-
|
(8,620)
|
Warrant
issue *
|
-
|
(108,509)
|
-
|
-
|
(108,509)
|
Loss for
the financial period
|
-
|
-
|
-
|
(136,351)
|
(136,351)
|
Balance
at 30 November 2023
|
3,203,532
|
10,726,620
|
450,658
|
(4,548,661)
|
9,832,109
|
|
|
|
|
|
|
Balance
at 1 June 2022
|
3,191,807
|
9,959,181
|
450,658
|
(4,120,843)
|
9,480,803
|
Issue of
share capital
|
-
|
-
|
-
|
-
|
-
|
Share
issue costs
|
-
|
-
|
-
|
-
|
-
|
Share
based payments
|
-
|
-
|
-
|
-
|
-
|
Loss for
the financial period
|
-
|
-
|
-
|
(168,786)
|
(168,786)
|
Balance
at 30 November 2022
|
3,191,807
|
9,959,181
|
450,658
|
(4,289,629)
|
9,312,017
|
Share
capital
The share
capital comprises the nominal value share capital issued for cash
and non-cash consideration. The share capital also comprises
deferred share capital. The deferred share
capital*
arose
through the restructuring of share capital which was approved at an
Annual General Meeting held on 9 December
2016.
Authorised
share capital:
The
authorised share capital at 30 November
2021 compromised 7,301,301,041 ordinary shares of €0.00025
each, and 317,785,034 deferred shares of €0.00999
each*
(€5,000,000),
(30 November 2020: 7,301,301,041
ordinary shares of €0.00025 each, and 317,785,034 deferred shares
of €0.00999 each*
(€5,000,000)).
*Capital
reorganisation:
Following
approval at an Annual General Meeting (“AGM”) held on 9 December 2016, the Company reorganised its
share capital by subdividing and reclassifying each issued ordinary
share of €0.01 as one ordinary share of €0.00001 each and one
deferred share of €0.00999 each.
The
Deferred Shares have no right to vote, attend or speak at general
meetings of the Company and have no right to receive any dividend
or other distribution, and have only limited rights to participate
in any return of capital on a winding-up or liquidation of the
Company, which will be of no material value. No application was
made to the London Stock Exchange for admission of the Deferred
Shares to trading on the AIM.
Consolidated
shares:
On
21 December 2017, the Company passed
a Special Resolution at the Company’s AGM, that all of the ordinary
shares of €0.00001 each in the capital of the Company, whether
issued or unissued were consolidated into New Ordinary Shares of
€0.00025 each in the capital of the Company (“consolidated shares”)
on the basis of one consolidated share for every 25 existing
ordinary shares. Following the consolidation of the ordinary shares
on 21 December 2017, the warrants in
issue were consolidated into one consolidated warrant for every 25
existing warrants. The exercise price in relation to the warrants
was also adjusted at this time (see Note 2).
Share
and Warrant issues during the period:
During the
period ended 30 November 2023, the
Company raised £150,000 through the issue of 6,000,000 ordinary
shares of the company at a price of £0.025 per Subscription
Share.
In
addition, Professor Richard Conroy
and Dr Sorca Conroy both subscribed for 2,000,000 shares each in
addition to this amount bringing the total amount raised to
£250,000.
As part of
this fundraise, 10,000,000 warrants at £0.04 per share were issued,
the value of which at date of issue was deducted from share premium
in line with the Company’s accounting policies.
There were
no share issues in the period ending 30
November 2022.
Share
premium
The share
premium comprises the excess consideration received in respect of
share capital over the nominal value of the shares issued as
adjusted for the costs of share issue in line with the Company’s
accounting policies.
Share
based payment reserve
The share
based payment reserve comprises of the fair value of all share
options and warrants which have been charged over the vesting
period, net of amounts relating to share options and warrants
forfeited, exercised or lapsed during the period, which are
reclassified to retained earnings.
Retained
losses
This
reserve represents the accumulated losses incurred by the Company
up to the condensed statement of financial position
date.
The
accompanying notes form an integral part of these condensed
financial statements.
1
Accounting
policies
Reporting
entity
Karelian
Diamond Resources plc (the “Company”) is a company domiciled in
Ireland.
Basis
of preparation and statement of compliance
The
condensed financial statements for the six months ended
30 November 2023 are
unaudited.
The
condensed financial statements have been prepared in accordance
with International Accounting Standard (“IAS”) 34:
Interim
Financial Reporting.
The
condensed financial statements do not include all the information
and disclosures required in the annual financial statements, and
should be read in conjunction with the Company’s annual financial
statements as at 31 May 2023, which
are available on the Company’s website -
www.kareliandiamondresources.com. The
accounting policies adopted in the presentation of the condensed
financial statements are consistent with those followed in the
preparation of the Company’s annual financial statements for the
year ended 31 May 2023.
The
condensed financial statements have been prepared under the
historical cost convention, except for derivative financial
instruments which are measured at fair value at each reporting
date.
The
condensed financial statements are presented in Euro (“€”). € is
the functional currency of the Company.
The
preparation of condensed financial statements requires the Board of
Directors and management to use judgements, estimates and
assumptions that affect the application of policies and reported
amounts of assets, liabilities, income and expenses. Actual results
may differ from those estimates. Estimates and underlying
assumptions are reviewed on an ongoing basis. Revisions to
accounting estimates are recognised in the financial period in
which the estimate is revised and in any future financial periods
affected. Details of critical judgements are disclosed in the
accounting policies detailed in the annual financial
statements.
The
financial information presented herein does not amount to statutory
financial statements that are required by Chapter 4 part 6 of the
Companies Act 2014 to be annexed to the annual return of the
Company. The statutory financial statements for the financial year
ended 31 May 2023 were annexed to the
annual return and filed with the Registrar of Companies. The audit
report on those financial statements was unqualified.
These
condensed financial statements were authorised for issue by the
Board of Directors on 28 February
2024.
Going
concern
The
Company recorded a loss of €136,351 for the six-month period ended
30 November 2023 (30 November 2022: loss of €168,786). The Company
had net current liabilities of €1,379,302 at that date
(30 November 2022:
€1,677,047).
The Board
of Directors have considered carefully the financial position of
the Company and in that context, have prepared and reviewed cash
flow forecasts for the period to 28 February
2025. As set out further in the Chairman’s statement, the
Company expects to incur capital expenditure in 2024, consistent
with its strategy as an exploration company. In reviewing the
proposed work programme for exploration and evaluation assets, the
results obtained from the exploration programme and the prospects
for raising additional funds as required, the Board of Directors
are satisfied that it is appropriate to prepare the financial
statements on a going concern basis.
Statement
of compliance
The
Company’s financial statements have been prepared in accordance
with IFRS as adopted by the European Union (“EU”).
Recent
accounting pronouncements
The
following new standards and amendments to standards have been
issued by the International Accounting Standards Board but have not
yet been endorsed by the EU, accordingly, none of these standards
have been applied in the current year. The Board of Directors is
currently assessing whether these standards once endorsed by the EU
will have any impact on the financial statements of the
Company.
-
Amendments
to IFRS 10 and IAS 28: Sale or contribution of assets between an
investor and its associate or joint venture – Postponed
indefinitely;
-
Amendments
to IFRS 16 Leases: Lease liability in a sale and leaseback –
Effective date 1 January 2024;
and
-
Amendments
to IAS 1 Presentation of Financial Statements: Classification of
liabilities as current or non-current and classification of
liabilities as current or non-current – Effective date 1 January 2024.
2
Profit/(loss)
per share
Basic
earnings per share
|
|
|
|
|
|
|
|
|
|
|
Six-month
period ended 30 November 2023 (Unaudited) €
|
|
Six-month
period ended 30 November 2022 (Unaudited) €
|
|
Year
ended 31 May 2023
(Audited)
€
|
Profit/(loss)
for the financial period/year attributable to equity holders of the
Company
|
|
|
(136,351)
|
|
(168,786)
|
|
(291,467)
|
|
|
|
|
|
|
|
|
Number of
ordinary shares for the purposes of earnings per share
|
|
|
95,096,311
|
|
68,542,749
|
|
76,460,146
|
|
|
|
|
|
|
|
|
Basic
earnings/(loss) per ordinary share
|
|
|
(€0.0014)
|
|
(€0.0025)
|
|
(€0.0038)
|
|
|
|
|
|
|
|
|
|
|
Diluted
earnings/(loss) per share
The effect
of share options and warrants is anti-dilutive.
3 Intangible
assets
Exploration
and evaluation assets
|
|
|
|
|
|
|
|
|
Cost
|
30
November 2023 (Unaudited) €
|
|
30
November 2022 (Unaudited) €
|
|
31 May
2023
(Audited)
€
|
At 1
June
|
11,265,894
|
|
10,910,931
|
|
10,910,931
|
Expenditure
during the financial period/year
|
|
|
|
|
|
-
License
and appraisal costs
|
93,258
|
|
18,510
|
|
269,314
|
|
80,693
|
|
59,769
|
|
85,649
|
At 30
November/31 May
|
11,439,845
|
|
10,989,210
|
|
11,265,894
|
|
|
|
|
|
|
|
|
|
Exploration
and evaluation assets relate to expenditure incurred in the
development of mineral exploration opportunities.
These
assets are carried at historical cost and have been assessed for
impairment in particular with regard to the requirements of IFRS
6: Exploration
for and Evaluation of Mineral Resources relating
to remaining licence or claim terms, likelihood of renewal,
likelihood of further expenditure, possible discontinuation of
activities as a result of specific claims and available data which
may suggest that the recoverable value of an exploration and
evaluation asset is less than its carrying
amount.
The Board
of Directors have considered the proposed work programmes for the
underlying mineral resources. They are satisfied that there are no
indications of impairment.
The Board
of Directors note that the realisation of the intangible assets is
dependent on further successful development and ultimate production
of the mineral resources and the availability of sufficient finance
to bring the resources to economic maturity and
profitability.
4 Commitments
and Contingencies
At
30 November 2023, there were no
capital commitments or contingent liabilities (31 May 2023: No capital commitments or
contingencies liabilities). Should the Company decide to develop
the Lahtojoki project, an amount of €40,000 is payable by the
Company to the vendors of the Lahtojoki mining
concession.
5 Convertible
Loan
On
26 May 2023, the Company entered into
a convertible loan note agreement for a total amount of €129,550
(£112,500) with Conroy Gold and
Natural Resources P.L.C. which is both a shareholder in the company
and has a number of other connections as noted in Note
7.
The
convertible loan note is unsecured, has a term of 18 months and
attracts interest at a rate of 5% per annum which is payable on the
maturity or conversion of the convertible loan. The conversion
price is 5 pence. The shareholder has
the right to seek conversion of the principal amount outstanding on
the convertible loan note and all interest accrued at any time
during the term.
The amount
of €10,304 relates to derivative liability attached to the total
convertible loan note at date of issue above and the net amount of
€119,246 was recorded as the value of the convertible loan at
31 May 2023. The value of the
convertible loan including interest at 30
November 2023 was €122,483 and is classified as a
non-current liability.
6
Warrant
liabilities
The
Company holds Sterling based warrants. The Company estimates the
fair value of the sterling-based warrants using the Binomial
Lattice Model. The determination of the fair value of the warrants
is affected by the Company’s share price along with other
assumptions.
The fair
value of the warrants in issue as at 30
November 2023 was €95,606. 10,000,000 warrants at a price of
£0.04 were issued during the period and 600,000 warrants were
exercised during the period at a price of £0.02.
7 Related
party transactions
(a)Apart
from Directors’ remuneration, equity investment from Directors, and
loans from shareholders, (who are also Directors), there have been
no contracts or arrangements entered into during the six-month
period in which a Director of the Company had a material
interest.
(b) The
Company shares accommodation and staff with Conroy Gold and Natural Resources plc which have
certain common Directors and shareholders. For the six-month period
ended 30 November 2023, Conroy Gold and Natural Resources plc incurred
costs totalling €49,596 (30 November
2022: €34,846) on behalf of the Company.
These
costs were recharged to the Company by Conroy Gold and Natural Resources
plc.
At
30 November 2023, Conroy Gold and Natural Resources plc was owed
€69,870 (30 November 2022: €234,651)
by the Company.
(c) In
May 2023, Conroy Gold and Natural Resources P.L.C. converted
amounts owing to it equivalent to €143,943 (£125,000) into ordinary
equity in the Company and a further €129,550 (£112,500) into a
convertible loan instrument as detailed in Note 5.
8 Subsequent
events
There were
no material events subsequent to the reporting date which
necessitate revision of the figures or disclosures included in the
financial statements.
9 Approval
of the condensed financial statements
These
condensed financial statements were approved by the Board of
Directors on 28 February 2024.
A copy of
the condensed financial statements will be available on the
Company’s website
www.kareliandiamondresources.com on 29
February 2024.